Intercept already has a revenue stream in place from sales of OCA in a lower-dose formulation, branded as Ocaliva, that is used to treat another form of liver disease called primary biliary ...

This week on The Intercept Briefing, we ask Intercept reporters what’s on their radar as a new president and a Republican-controlled Congress take office. They’ll be watching the tentative ...